No insider purchase over the last 90 days. The latest, by Egan Kenneth F, was filed 18 Mar 2025.
Olaplex Holdings, Inc., classified in the Luxury & Fashion sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Between 21 October 2025 and 21 October 2026, 16 insiders published 35 filings.
There is no open-market purchase to report; the filings show 9 sales worth €1.1M by 4 insiders. Baldwin Amanda filed the largest sale, €459k, on 16 March 2026.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (5,808 companies, median 19 filings), a count of 35 filings is above the norm. Looking back to 2021, when coverage begins, insiders filed 9 purchases and 20 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 423.0 m USD and net income of -9.3 m USD.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 113 declarations
OLAPLEX HOLDINGS, INC. (NASDAQ: OLPX) is a United States-based premium haircare company listed on the NASDAQ market. The business built its reputation around a patented, science-led bond-building technology that was introduced in 2014 and first adopted by professional hairstylists before expanding into consumer channels. For investors, OLAPLEX represents a focused branded beauty platform with strong category awareness, premium pricing power relative to mass-market haircare, and a business model that relies heavily on professional endorsement, product innovation, and omnichannel execution.
The company operates through three main distribution channels: Professional, Specialty Retail, and Direct-to-Consumer. The Professional channel is strategically important because it anchors the brand within salons and among hairstylists, who are a core source of product advocacy and consumer conversion. Specialty retail extends brand visibility and helps OLAPLEX reach a broader prestige audience, while DTC supports full-brand engagement and higher-margin direct relationships with consumers. This channel mix is central to OLAPLEX’s competitive positioning versus larger beauty conglomerates and smaller niche haircare brands.
Founded in 2014, OLAPLEX built its brand around hair-health solutions designed to protect, strengthen, and relink damaged bonds in the hair. Its portfolio spans professional salon treatments, wash-care products, styling products, and at-home maintenance routines. The company markets itself as a science-enabled and innovation-driven haircare brand, with messaging centered on healthy hair rather than cosmetic styling alone. That positioning has helped OLAPLEX establish a differentiated presence in prestige haircare, a segment supported by consumer trading-up behavior and recurring replenishment demand.
Geographically, OLAPLEX is rooted in the United States, its home market, while also pursuing international growth, particularly in Europe and other key markets. The company’s primary executive office is in New York, although its brand heritage is closely linked to Santa Barbara, California, where the chemistry behind the brand was originally developed. OLAPLEX’s manufacturing footprint is also relevant, with finished products produced in the United States and Europe, including a meaningful portion made in California.
Recent developments are material for the equity story. OLAPLEX reported first-quarter 2026 results on May 11, 2026, following its full-year 2025 results in March 2026. In 2025, management continued its multi-year transformation, refreshed the board, and announced the acquisition of biotech company Purvala to support future product innovation. Most notably, in March 2026 the company announced a definitive agreement to be acquired by Henkel AG & Co. KGaA in an all-cash transaction; if completed, OLAPLEX would no longer remain listed on the NASDAQ. That transaction is a major strategic event and frames the near-term outlook for shareholders.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 423.0 m USD | -9.3 m USD | -0.01 USD | 10-K |
| Dec 2024 | 422.7 m USD | 19.5 m USD | 0.03 USD | 10-K |
| Dec 2023 | 458.3 m USD | 61.6 m USD | 0.09 USD | 10-K |
| Dec 2022 | 704.3 m USD | 244.1 m USD | 0.35 USD | 10-K |
| Dec 2021 | 598.4 m USD | 220.8 m USD | 0.32 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.